<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31057541</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>10</Volume>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Muckle-Wells Syndrome Across Four Generations in One Czech Family: Natural Course of the Disease.</ArticleTitle>
        <Pagination>
          <StartPage>802</StartPage>
          <MedlinePgn>802</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">802</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2019.00802</ELocationID>
        <Abstract>
          <AbstractText><b>Background:</b> Muckle-Wells syndrome (MWS) represents a moderate phenotype of cryopyrinopathies. Sensorineural hearing loss and AA amyloidosis belong to the most severe manifestations of uncontrolled disease. Simultaneous discovery of MWS in four generations of one large kindred has enabled us to document natural evolution of untreated disease and their response to targeted therapy. <b>Methods:</b> A retrospective case study, clinical assessment at the time of diagnosis and 2-year prospective follow-up using standardized disease assessments were combined. <b>Results:</b> Collaborative effort of primary care physicians and pediatric and adult specialists led to identification of 11 individuals with MWS within one family. Presence of p.Ala441Val mutation was confirmed. The mildest phenotype of young children suffering with recurrent rash surprised by normal blood tests and absence of fevers. Young adults all presented with fevers, rash, conjunctivitis, and arthralgia/arthritis with raised inflammatory markers. Two patients aged over 50 years suffered with hearing loss and AA amyloidosis. IL-1 blockade induced disease remission in all individuals while hearing mildly improved or remained stable in affected patients as did renal function in one surviving individual with amyloidosis. <b>Conclusions:</b> We have shown that severity of MWS symptoms gradually increased with age toward distinct generation-specific phenotypes. A uniform trajectory of disease evolution has encouraged us to postpone institution of IL-1 blockade in affected oligosymptomatic children. This report illustrates importance of close interdisciplinary collaboration.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fingerhutová</LastName>
            <ForeName>Šárka</ForeName>
            <Initials>Š</Initials>
            <AffiliationInfo>
              <Affiliation>Paediatric Rheumatology and Autoinflammatory Diseases Unit, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, General University Hospital in Prague, Charles University, Prague, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fráňová</LastName>
            <ForeName>Jana</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Paediatric Rheumatology, University Hospital Brno, Brno, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hlaváčková</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno and Faculty of Medicine, Masaryk University, Brno, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jančová</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Nephrology, First Faculty of Medicine, General University Hospital in Prague, Charles University, Prague, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Procházková</LastName>
            <ForeName>Leona</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Rheumatology, St. Anne's University Hospital Brno, Brno, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beránková</LastName>
            <ForeName>Kamila</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory for Study of Mitochondrial Disorders, First Faculty of Medicine, General University Hospital in Prague, Charles University, Prague, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tesařová</LastName>
            <ForeName>Markéta</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Laboratory for Study of Mitochondrial Disorders, First Faculty of Medicine, General University Hospital in Prague, Charles University, Prague, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Honsová</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical and Transplant Pathology Centre, Institute for Clinical and Experimental Medicine, Prague, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doležalová</LastName>
            <ForeName>Pavla</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Paediatric Rheumatology and Autoinflammatory Diseases Unit, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, General University Hospital in Prague, Charles University, Prague, Czechia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>04</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007375">Interleukin-1</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056587" MajorTopicYN="N">Cryopyrin-Associated Periodic Syndromes</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018153" MajorTopicYN="N" Type="Geographic">Czech Republic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005191" MajorTopicYN="N">Family Characteristics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005192" MajorTopicYN="N">Family Health</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007375" MajorTopicYN="N">Interleukin-1</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">AA amyloidosis</Keyword>
        <Keyword MajorTopicYN="Y">Muckle-Wells syndrome (MWS)</Keyword>
        <Keyword MajorTopicYN="Y">cryopyrin-associated periodic syndromes (CAPS)</Keyword>
        <Keyword MajorTopicYN="Y">cryopyrinopathy</Keyword>
        <Keyword MajorTopicYN="Y">familial cold autoinflammatory syndrome (FCAS)</Keyword>
        <Keyword MajorTopicYN="Y">hearing loss</Keyword>
        <Keyword MajorTopicYN="Y">rash</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>9</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31057541</ArticleId>
        <ArticleId IdType="pmc">PMC6477140</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2019.00802</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Lequerré T, Vittecoq O, Saugier-Veber P, Goldenberg A, Patoz P, Frébourg T, et al. . A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology. (2007) 46:709–14. 10.1093/rheumatology/kel399</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kel399</ArticleId>
            <ArticleId IdType="pubmed">17178739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tilson H, Primatesta P, Kim D, Rauer B, Hawkins PN, Hoffman HM, et al. . Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry. Orphanet J Rare Dis. (2013)8:139. 10.1186/1750-1172-8-139</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1750-1172-8-139</ArticleId>
            <ArticleId IdType="pmc">PMC3848430</ArticleId>
            <ArticleId IdType="pubmed">24016338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy R, Gérard L, Kuemmerle-Deschner J, Lachmann HJ, Koné-Paut I, Cantarini L, et al. . Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. (2015) 74:2043–9. 10.1136/annrheumdis-2013-204991</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2013-204991</ArticleId>
            <ArticleId IdType="pubmed">25038238</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chetrit BE, Gattorno M, Gul A, Kastner DL, Lachman HJ, Touitou I, et al. 
Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study. Ann Rheum Dis. (2018) 77:1558–65. 10.1136/annrheumdis-2017-212515</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2017-212515</ArticleId>
            <ArticleId IdType="pubmed">30100561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuemmerle-Deschner JB, Koitschev A, Ummenhofer K, Hansmann S, Plontke SK, Koitschev C, et al. . Hearing loss in muckle-wells syndrome. Arthritis Rheum. (2013) 65:824–31. 10.1002/art.37810</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.37810</ArticleId>
            <ArticleId IdType="pubmed">23440695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahmadi N, Brewer CC, Zalewski C, King KA, Butman JA, Plass N, et al. . Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations. Otolaryngol Head Neck Surg. (2011) 145:295–302. 10.1177/0194599811402296</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0194599811402296</ArticleId>
            <ArticleId IdType="pmc">PMC3407887</ArticleId>
            <ArticleId IdType="pubmed">21493283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawkins PN, Lachmann HJ, Agana E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to Anakinra. Arthritis Rheum. (2004) 50:607–12. 10.1002/art.20033</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.20033</ArticleId>
            <ArticleId IdType="pubmed">14872505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdulla MC, Alungal J, Hawkins PN, Mohammed S. Muckle-Wells syndrome in an Indian family associated with NLRP3 mutation. J Postgrad Med. (2015) 61:120–2. 10.4103/0022-3859.153107</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0022-3859.153107</ArticleId>
            <ArticleId IdType="pmc">PMC4943435</ArticleId>
            <ArticleId IdType="pubmed">25766347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piram M, Koné-Paut I, Lachmann HJ, Frenkel J, Ozen S, Kuemmerle-Dechner J, et al. . Validation of the auto-inflammatory diseases activity Index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. (2014) 73:1–6. 10.1136/annrheumdis-2013-203666</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2013-203666</ArticleId>
            <ArticleId IdType="pmc">PMC4251184</ArticleId>
            <ArticleId IdType="pubmed">24026675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ter Haar NM, Annink KV, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, et al. . Development of the autoinflammatory disease damage index (ADDI). Ann Rheum Dis. (2017) 76:821–30. 10.1136/annrheumdis-2016-210092</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2016-210092</ArticleId>
            <ArticleId IdType="pubmed">27811147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verna D, Sarndahl E, Andersson H, Eriksson P, Fredrikson M, Jonsson JI, et al. 
The Q705k polymorphism in Nlrp3 is a gain-of-function alteration leading to excessive interleukin-1β and Il-18 production. PLoS ONE. (2012) 7:e34977
10.1371/Journal.Pone.0034977</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/Journal.Pone.0034977</ArticleId>
            <ArticleId IdType="pmc">PMC3328489</ArticleId>
            <ArticleId IdType="pubmed">22529966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pereira AF, Pereira Lb, Vale Ec, Tanure La. Four cases of muckle-wells syndrome within the same family. An Bras Dermatol. (2010) 85:907–11. 10.1590/S0365-05962010000600022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0365-05962010000600022</ArticleId>
            <ArticleId IdType="pubmed">21308320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorlin RJ, Toriello HV, Cohen MMJ.
Hereditary Hearing Loss and Its Syndromes.
New York, NY: Oxford University Press;  (1995). p. 243.</Citation>
        </Reference>
        <Reference>
          <Citation>Kuemmerle-Deschner JB, Lohse P, Koetter I, Dannecker Ge, Reess F, Ummenhofer K, et al. . Nlrp3 E311k mutation in a large family with muckle-wells syndrome-description of a heterogeneous phenotype and response to treatment. Arthritis Res Ther. (2011) 13:R196. 10.1186/Ar3526</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/Ar3526</ArticleId>
            <ArticleId IdType="pmc">PMC3334646</ArticleId>
            <ArticleId IdType="pubmed">22146561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maksimovic L, Stirnemann J, Caux F, Ravet N, Rouaghe S, Cuisset L, et al. . New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes. Rheumatology. (2008) 47:309–10. 10.1093/rheumatology/kem318</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/kem318</ArticleId>
            <ArticleId IdType="pubmed">18174231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weegerink NJ, Schraders M, Leijendeckers J, Slieker K, Huygen PL, Hoefsloot L, et al. . Audiometric characteristics of a Dutch family with Muckle-Wells syndrome. Hear Res. (2011) 282:243–51. 10.1016/j.heares.2011.07.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.heares.2011.07.006</ArticleId>
            <ArticleId IdType="pubmed">21810457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Headley AP, Cordingley F, Hawkins PN, Riminton DS. Muckle-Wells cryopyrinopathy: complex phenotyping and response to therapy in a new multiplex kindred. Inflammation. (2014) 37:396–401. 10.1007/s10753-013-9752-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10753-013-9752-6</ArticleId>
            <ArticleId IdType="pubmed">24150829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alejandre N, Ruiz-Palacios A, García-Aparicio AM, Blanco-Kelly F, Bermúdez S, Fernández-Sanz G, et al. . Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation. Rheumatology. (2014) 53:1095–9. 10.1093/rheumatology/ket486</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/ket486</ArticleId>
            <ArticleId IdType="pubmed">24501247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuemmerle-Deschner JB, Tyrell PN, Reess F, Kotter I, Lohse P, Girschick H, et al. 
Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum. (2010) 62:3783–91. 10.1002/art.27696</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.27696</ArticleId>
            <ArticleId IdType="pubmed">20722029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lane T, Loeffler JM, Rowczenio DM, Gilbertson JA, Bybee A, Russell TL, et al. . AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis Rheum. (2013) 65:1116–21. 10.1002/art.37827</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.37827</ArticleId>
            <ArticleId IdType="pubmed">23280696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hentgen V, Despert V, Lepretre AC, Cuisset L, Chevrant-Breton J, Jégo P, et al. . Intrafamilial variable phenotypic expression of a CIAS1 mutation: from Muckle-Wells to chronic infantile neurological cutaneous and articular syndrome. J Rheumatol. (2005) 32:747–51. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15801036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuh E, Lohse P, Ertl-Wagner B, Witt M, Krumbholz M, Frankenberger M, et al. . Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations. Neurol Neuroimmunol Neuroinflamm. (2015) 2:e109. 10.1212/NXI.0000000000000109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/NXI.0000000000000109</ArticleId>
            <ArticleId IdType="pmc">PMC4436598</ArticleId>
            <ArticleId IdType="pubmed">26020059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dode C, Le Du N, Cuisset L, Letourneur F, Barthelot JM, Vaudour G, et al. . New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet. (2002) 70:1498–506. </Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC379138</ArticleId>
            <ArticleId IdType="pubmed">11992256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial coldautoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. (2001) 29:301–5. 10.1038/ng756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng756</ArticleId>
            <ArticleId IdType="pmc">PMC4322000</ArticleId>
            <ArticleId IdType="pubmed">11687797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leslie KS, Lachmann HJ, Bruning E, McGrath JA, Bybee A, Galimore JR, et al. . Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations. Arch Dermatol. (2006) 142:1591–7. 10.1001/archderm.142.12.1591</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archderm.142.12.1591</ArticleId>
            <ArticleId IdType="pubmed">17178985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuemmerle-Deschner JB, Tyrrell PN, Koetter I, Wittkowski H, Bialkowski A, Tzaribcahev N, et al. . Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. Arthritis Rheum. (2011) 63:840–9. 10.1002/art.30149</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.30149</ArticleId>
            <ArticleId IdType="pubmed">21360513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rynne M, Maclean C, Bybee A, McDermott MF, Emery P. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Ann Rheum Dis. (2006) 65:533–4. 10.1136/ard.2005.038091</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.2005.038091</ArticleId>
            <ArticleId IdType="pmc">PMC1798106</ArticleId>
            <ArticleId IdType="pubmed">16531551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, et al. . Recommendations for the management of autoinflammatory diseases. Ann Reum Dis. (2015) 74:1636–44. 10.1136/annrheumdis-2015-207546</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2015-207546</ArticleId>
            <ArticleId IdType="pubmed">26109736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, et al. . Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. (2002) 46:2445–52. 10.1002/art.10509</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.10509</ArticleId>
            <ArticleId IdType="pubmed">12355493</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
